AGREEMENT BETWEENManufacturing and Supply Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
MANUFACTURING AND SUPPLY AGREEMENT [DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension]Manufacturing and Supply Agreement • September 27th, 2012 • Lantheus Medical Imaging, Inc. • Pharmaceutical preparations • New York
This Manufacturing and Supply Agreement (this “Agreement”), dated as of February 1, 2012 (the “Effective Date”), is hereby entered into by and between Lantheus Medical Imaging, Inc., a corporation organized and existing under the laws of Delaware with its principal place of business at 331 Treble Cove Road, North Billerica, MA 01862 (“LMI”), and Jubilant HollisterStier LLC, a limited liability company organized and existing under the laws of Delaware with a place of business at 3525 North Regal Street, Spokane, Washington, 99207 (“HSL”). LMI and HSL are referred to herein individually as a “Party” and collectively as the “Parties”.
MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN PFIZER INC. AND UPJOHN INC. DATED AS OF NOVEMBER 16, 2020Manufacturing and Supply Agreement • November 19th, 2020 • Viatris Inc • Pharmaceutical preparations • Delaware
THIS MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated as of November 16, 2020 (the “Effective Date”), is by and between Pfizer Inc., a Delaware corporation (hereinafter “Manufacturer”), and Upjohn Inc., a Delaware corporation (hereinafter “Customer”). Manufacturer and Customer may be referred to herein individually as a “Party” or collectively as the “Parties”.
MANUFACTURING AND SUPPLY AGREEMENT relating to the separation of the Alcon surgical and vision care business Puurs/Barcelona/BrazilManufacturing and Supply Agreement • April 9th, 2019 • Alcon Inc • Ophthalmic goods
CONFIDENTIAL- CONFIDENCIAL CONFIDENTIAL- CONFIDENCIALManufacturing and Supply Agreement • December 2nd, 2022 • New York
THIS MANUFACTURING AND SUPPLYAGREEMENT dated as of February 2, 2021 (the “Effective Date”) is made by and between PFIZER EXPORT BV with offices at Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Netherlands (hereinafter “Pfizer”) and Fiduprevisora S.A., as the legal representative and administrator of the Autonomous Patrimony of the National Fund for Disaster Risk Management – Subaccount for the mitigation of emergencies COVID -19 (“FNGRD”) acting as instructed by the Director of the National Disaster and Risk Management Unit (UNGRD), (hereinafter “Purchaser”). Purchaser and Pfizer may be referred to herein individually as a “Party” or collectively as the “Parties”. ESTE ACUERDO DE FABRICACIÓN YSUMINISTRO de fecha 2 de febrero de 2021 (la “Fecha Efectiva”) se celebra entre PFIZER EXPORT BV con domicilio en Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Holanda (en adelante, “Pfizer”) y Fiduprevisora S.A. como representante legal y administradora del Patrimonio Autónomo del
Exhibit 10.47 MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement ("Agreement") is entered into as of the date signed by the last party to sign this Agreement, and with an effective date of February 8, 2006 (the "Effective...Manufacturing and Supply Agreement • April 3rd, 2006 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Delaware
MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • October 28th, 2021 • New York
THIS MANUFACTURING AND SUPPLY AGREEMENT effective as of the date of the last signature below (the “Effective Date”) is made by and among Pfizer Export B.V., a company established under the laws of the Netherlands with its registered office at Rivium Westlaan 142, 2909LD Capelle aan den Ijssel, the Netherlands (hereinafter “Pfizer”) and Albania Ministry of Health and Social Protection, acting on its own behalf and on behalf of the Republic of Albania with offices at Kavaja St 25, Tirana 1001 (“MOH”), Albanian Minister of State for Reconstruction,acting on its own behalf and on behalf of the Republic of Albania with offices at Boulevard “Dëshmorët e Kombit”, Tirana 1001 (MOR) and Institute of Public Health, acting on its own behalf and on behalf of the Republic of Albania with offices at Rr. Aleksander Moisiu, nr. 80, Tirana, 1001 (“IPH”) (MOH,MORand IPH, individually and collectively referred to hereinafter as “Purchaser”). Purchaser and Pfizer may be referred to herein individually as
EX-10.23 24 filename24.htm ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 MANUFACTURING AND SUPPLY AGREEMENT effective as of this 9...Manufacturing and Supply Agreement • May 5th, 2020 • New York
WHEREAS, GW is a company engaged in the processing and supply of pharmaceutical products holding the necessary manufacturing licenses and permits in this respect;
EX-10.12 18 a2236601zex-10_12.htm EX-10.12Manufacturing and Supply Agreement • May 5th, 2020
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 25th, 2005 • Skinmedica Inc • Pharmaceutical preparations • California
THIS MANUFACTURING AND SUPPLY AGREEMENT is entered into effective as of June 30, 2002 (“Effective Date”), by and between ENHANCED DERM TECHNOLOGIES, INC., a Delaware corporation (“EDT”) and SKINMEDICA, INC., a California corporation (“SM”). EDT and SM are each referred to as a “Party” to this Agreement, and collectively as the “Parties.”
AMENDMENT NO.1 TO A MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 2nd, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • Delaware
WHEREAS The Parties entered into an “Amended and Restated Manufacturing and Supply Agreement” on October 9th, 2018 (the “Main Agreement”);
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • February 28th, 2022 • Pacira BioSciences, Inc. • Pharmaceutical preparations
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) dated as of July 31, 2015 (the “Effective Date”) is made by and between Flexion Therapeutics, Inc., a Delaware corporation having its principal place of business at 10 Mall Road, Suite 301, Burlington, Massachusetts, United States (“Flexion”) and Patheon UK Limited, a company incorporated in England and Wales having its principal place of business at Kingfisher Drive, Covingham, Swindon, SN35BZ, United Kingdom (“Patheon”). Flexion, and Patheon are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
RECITALSManufacturing and Supply Agreement • August 12th, 2002 • Allergan Inc • Pharmaceutical preparations • California
EX-10.2 3 a17-10836_1ex10d2.htm EX-10.2Manufacturing and Supply Agreement • May 5th, 2020 • New York
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
Manufacturing and Supply Agreement (Projekt H 2000)Manufacturing and Supply Agreement • February 6th, 2018 • Biofrontera AG • Pharmaceutical preparations
This Manufacturing and Supply Agreement (together with its Attachments, which are incorporated herein by reference, the "Agreement") is made on June 1st, 2015 (the "Effective Date") by and between Hapila GmbH, Otto-Schott-Straße 9, 07552 Gera, Germany ("Hapila") and Biofrontera Pharma GmbH, HemmelratherWeg 201, D-51377 Leverkusen, Germany ("Biofrontera"). Hapila and Biofrontera are hereinafter also referred to individually as "Party" or collectively as "Parties".
Exhibit 10.68 IGI Technology making a difference July 5, 2001 Mr. Bob Bennett Director of Sales and Marketing Prime Pharmaceutical Corporation 299 Rimrock Road North York, Ontario M3J 3C6 Dear Bob: Attached is a signed acknowledgement of our...Manufacturing and Supply Agreement • March 15th, 2002 • Igi Inc • Biological products, (no disgnostic substances)
EX-10.1 2 d338151dex101.htm MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • May 5th, 2020 • California
This Manufacturing and Supply Agreement (the “Agreement”) effective as of March 21, 2012 (the “Effective Date”) is entered into by and between Corcept Therapeutics Incorporated, a Delaware corporation located at 149 Commonwealth Drive, Menlo Park, CA 94025 (“Corcept”) and Formulation Technologies, LLC D/B/A PharmaForm, LLC a Texas Limited Liability corporation located at 11501 Domain Drive, Suite 130, Austin, TX 78758 (“PharmaForm”). Corcept and PharmaForm are sometimes referred to individually as a “Party” and collectively as the “Parties”.
SEVENTH AMENDMENTManufacturing and Supply Agreement • November 3rd, 2021 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Seventh Amendment to the Manufacturing and Supply Agreement (the "Seventh Amendment") is made and effective as of August 2, 2021 (the "Seventh Amendment Effective Date") by and between W. R. Grace & Co. ("GRACE") and ChromaDex, Inc. ("ChromaDex").
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and is the type that the registrant treats as private or confidential. MANUFACTURING AND SUPPLY AGREEMENT FOR...Manufacturing and Supply Agreement • March 2nd, 2022 • Ascendis Pharma a/S • Pharmaceutical preparations
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 17th, 2018 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Texas
This Manufacturing and Supply Agreement (this “Agreement”) is entered into as of the Effective Date (as defined below) by and between (1) Apollo Endosurgery, Delaware corporation having offices at 1120 S Capital of Texas Highway #300, Austin, TX 78746 (“APOLLO”), and (2) Establishment Labs, S.A a corporation organized under the laws of Costa Rica and having a principal place of business at Coyol Free Zone, B15, Alajuela, 20113, Costa Rica (“ESTABLISHMENT”). APOLLO and ESTABLISHMENT shall hereinafter be individually referred to as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • March 7th, 2014 • Cerus Corp • Surgical & medical instruments & apparatus • Illinois
THIS AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is entered into by and between FENWAL, INC., a company organized under the laws of Delaware (“Fenwal”), and CERUS CORPORATION, a company organized under the laws of Delaware (“Cerus”). Fenwal and Cerus, as corporations, are sometimes referred to herein as a “Party” and collectively as the “Parties.” This Agreement shall become effective as of the last date of signature by the Parties (the “Effective Date”).
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT MARKED [***] HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION. MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • August 10th, 2006 • Abraxis BioScience, Inc. • Pharmaceutical preparations • Delaware
This MANUFACTURING AND SUPPLY AGREEMENT (“Agreement”) is made as of this 28th day of June, 2006, (the “Effective Date”) by and between ASTRAZENECA PHARMACEUTICALS LP, a Delaware limited partnership having a principal place of business at 1800 Concord Pike, Wilmington, Delaware, 19850, (“AZ”) and ABRAXIS BIOSCIENCE, INC., a Delaware corporation having a place of business at 11777 San Vincente Blvd., Suite 550, Los Angeles, CA 90049 (“ABBI”).
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • June 26th, 2015 • Amplify Snack Brands, INC • Food and kindred products • Illinois
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is dated as of February 27, 2014 (the “Effective Date”), between SKINNYPOP POPCORN LLC, a limited liability company organized under the laws of Illinois, (“Buyer”) and ASSEMBLERS FOOD PACKAGING LLC, a limited liability company organized under the laws of the state of Illinois (“Manufacturer” and together with Buyer, the “Parties”).
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES...Manufacturing and Supply Agreement • September 9th, 2011 • Coronado Biosciences Inc • Pharmaceutical preparations
This Manufacturing and Supply Agreement (the “Agreement”) is entered into this day of December, 2005 (the “Effective Date”), by and between Collingwood Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at 787 Seventh Avenue, 48th Floor, New York, New York 10019 (“Collingwood”), and Ovamed GmbH, a corporation organized and existing under the laws of Germany and having a principal place of business at Kiebitzhörn 33-35, 22885 Barsbüttel, Germany (“Ovamed”). Collingwood and Ovamed may each be referred to herein individually as a “Party” and collectively as the “Parties.”
EX-10 2 baxtermsagreement.htm MANUFACTURING AND SUPPLY AGREEMENT Confidential Manufacturing and Supply Agreement by and among Angiotech Pharmaceuticals, Inc. Angiotech International, GmbH Cohesion Technologies, Inc. and Baxter Healthcare Corporation...Manufacturing and Supply Agreement • May 5th, 2020 • New York
This Manufacturing and Supply Agreement (“Manufacturing Agreement”), dated as of April 1, 2003 (“Effective Date”) is entered into by and among:
CONFIDENTIAL TREATMENT AMENDMENT NO. 2 to the MANUFACTURING AND SUPPLY AGREEMENT entered into as of September 30, 2001 by and between ACS Dobfar, SpA and Cubist Pharmaceuticals, Inc.Manufacturing and Supply Agreement • November 4th, 2005 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
This AMENDMENT NO. 2 (“Amendment No. 2”), to that certain Manufacturing and Supply Agreement (the “Agreement”) entered into as of September 30, 2001, is made this 12th day of February, 2003, by and between ACS Dobfar, SpA, an Italian corporation (“ACSD”) and Cubist Pharmaceuticals, Inc., a Delaware corporation (“Cubist”). Unless otherwise defined herein, capitalized terms used but not defined herein shall have the meaning set forth in the Agreement, and the Agreement shall be amended to incorporate any additional definitions provided for in this Amendment No. 1, including definitions in the preamble and recitals hereto.
MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN SUCAMPO AG AND PAR PHARMACEUTICAL, INC. DATED AS OF FEBRUARY 5, 2015Manufacturing and Supply Agreement • March 9th, 2015 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Manufacturing and Supply Agreement (this “Agreement”) is hereby entered into and effective as of February 5, 2015 (the “Effective Date”) by and between Sucampo AG (“Sucampo”) and Par Pharmaceutical, Inc. (“Par”). Each of Sucampo and Par are referred hereto as the “Parties” or, individually, as a “Party”).
EX-10.1 2 a06-12926_1ex10d1.htm EX-10 InFocus Corporation And Hon Hai Precision Industry Company Limited Manufacturing and Supply Agreement This Agreement, having an “Effective Date” of September 1, 2005 is made and entered into by and between:Manufacturing and Supply Agreement • May 5th, 2020 • Oregon
InFocus Corporation, a corporation organized under the laws of Oregon, U.S.A., having its principal office at 27700B SW Parkway Avenue, Wilsonville, Oregon 97070, USA (herein “InFocus”); and Hon Hai Precision Industry Co. Ltd., a corporation organized under the laws of Taiwan, with registered trade name Foxconn, having its principal office at 2 Tzu Yu St. Tu-Cheng City, Taipei, Taiwan (herein “Supplier”).
Manufacturing and Supply AgreementManufacturing and Supply Agreement • May 11th, 2012 • Novaled AG • Electronic components & accessories
Novaled AG, Tatzberg 49, D-01307 Dresden, a company duly organised and existing under the laws of Germany registered at the local court of Dresden, represented by Gildas SORIN, acting in his capacity of Managing Executive Director,
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FIRST AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT FOR N-ACETYLCYSTEINEManufacturing and Supply Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT (the “First Amendment”) to that certain Manufacturing and Supply Agreement for N-Acetylcysteine (the "Agreement”), dated as of January 15, 2002, as modified by that certain Novation Agreement, dated as of January 27, 2006 (to be attached hereto), is entered into by and between CUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, United States (“CUMBERLAND”), and BIONICHE TEORANTA, a corporation organized and existing under the laws of Ireland (“BIONICHE”), and is effective as of November 16, 2006. Capitalized terms used but not defined in this First Amendment shall have the meanings that are set forth in the Agreement.
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • August 8th, 2014 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • California
THIS MANUFACTURING AND SUPPLY AGREEMENT (the “AGREEMENT”) is made effective as of the 27th day of September, 2004 (the “EFFECTIVE DATE”), by and between SANTARUS, INC., a Delaware corporation, having offices at 10590 West Ocean Air Drive, Suite 200, San Diego, California 92130, U.S.A. (“SANTARUS”) and OSG Norwich Pharmaceuticals Inc., a Delaware corporation, having offices at 6826 State Highway 12, Norwich, New York 13815 (“MANUFACTURER”). Manufacturer and Santarus are sometimes referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
September 5, 2012 Manufacturing and Supply AgreementManufacturing and Supply Agreement • May 12th, 2014 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
Corcept Therapeutics IncorporatedManufacturing and Supply Agreement • March 14th, 2014 • Corcept Therapeutics Inc • Pharmaceutical preparations
On behalf of Corcept Therapeutics Inc. (“Corcept”), I propose amending the Manufacturing and Supply Agreement between Corcept and PCAS dated November 3, 2006 (the “Agreement”) as follows:
AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • March 15th, 2011 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT (“Amendment No. 2”) is made and entered into as of February 15, 2011 (the “Effective Date of Amendment No. 2”) by and between Alexza Pharmaceuticals, Inc., a Delaware corporation having an address at 2091 Stierlin Court, Mountain View, CA 94043 (“Alexza”) and Autoliv ASP, Inc., an Indiana corporation having an address at 3350 Airport Road, Ogden Utah 84405 (“Autoliv”).
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • May 28th, 2021 • Century Therapeutics, Inc. • Biological products, (no disgnostic substances)
Century Therapeutics, Inc., (f/k/a Century Therapeutics, LLC) a company registered in Delaware, United States, whose registered office is at 3675 Market Street, Philadelphia, PA 19104, United States (hereafter referred to as: “CENTURY” or “Century”);
